D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 45 Citations 6,828 147 World Ranking 3927 National Ranking 118

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Cytokine
  • Cancer

Wei-Ping Min mainly investigates Immunology, Immune system, Small interfering RNA, Transplantation and Cell biology. Wei-Ping Min has researched Immunology in several fields, including Interleukin 12 and CD40. The study incorporates disciplines such as Fas ligand and Antigen in addition to Immune system.

Wei-Ping Min interconnects Gene silencing and RNA interference in the investigation of issues within Small interfering RNA. His studies in Gene silencing integrate themes in fields like RNA, Molecular biology and Cancer research. His biological study spans a wide range of topics, including Kidney and Acute tubular necrosis.

His most cited work include:

  • Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis (284 citations)
  • Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis (256 citations)
  • Inhibitory Feedback Loop Between Tolerogenic Dendritic Cells and Regulatory T Cells in Transplant Tolerance (237 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Immunology, Gene silencing, Cancer research, Transplantation and Small interfering RNA. His research ties CD40 and Immunology together. His Gene silencing research incorporates themes from Gene knockdown, Dendritic cell, Molecular biology, RNA interference and Cell biology.

His study focuses on the intersection of Cancer research and fields such as Cytotoxic T cell with connections in the field of Fas ligand. The various areas that he examines in his Transplantation study include Reperfusion injury and Ischemia. The Small interfering RNA study combines topics in areas such as Eosinophil, Immunoglobulin E and Allergy.

He most often published in these fields:

  • Immunology (71.50%)
  • Gene silencing (72.46%)
  • Cancer research (62.80%)

What were the highlights of his more recent work (between 2015-2021)?

  • Cancer research (62.80%)
  • Gene silencing (72.46%)
  • T cell (39.13%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Cancer research, Gene silencing, T cell, Immunotherapy and Immune system. His study in Cancer research is interdisciplinary in nature, drawing from both Cytotoxic T cell, Cancer, CD8 and Immunology. His work carried out in the field of Immunology brings together such families of science as Angiogenesis, Route of administration and CD40.

His Gene silencing study combines topics from a wide range of disciplines, such as Gene knockdown, Small interfering RNA, Downregulation and upregulation, Heart transplantation and Pathology. His T cell research incorporates elements of Proinflammatory cytokine, RELB, Endothelium and Arthritis. His Immune system research is multidisciplinary, relying on both Mucous membrane of nose and Nasal administration.

Between 2015 and 2021, his most popular works were:

  • Temperature-dependent cell death patterns induced by functionalized gold nanoparticle photothermal therapy in melanoma cells. (64 citations)
  • Temperature-dependent cell death patterns induced by functionalized gold nanoparticle photothermal therapy in melanoma cells. (64 citations)
  • miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion (53 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Cytokine
  • Cancer

Wei-Ping Min mostly deals with Cancer research, Gene silencing, Immunotherapy, Small interfering RNA and T cell. His Cancer research research is multidisciplinary, incorporating elements of Necrosis, Cancer cell, Immunology, Proinflammatory cytokine and Programmed cell death. His work deals with themes such as Angiogenesis, Cellular differentiation, Carcinogenesis, Macrophage polarization and Prostate cancer, which intersect with Immunology.

His Gene silencing research integrates issues from Cell cycle, Gene knockdown and Pathology. His Pathology research also works with subjects such as

  • Heart transplantation, Ischemia, Kidney transplantation, Tumor necrosis factor alpha and Reperfusion injury most often made with reference to Renal function,
  • Creatinine and Renal ischemia most often made with reference to Kidney. His Immunotherapy study incorporates themes from Cytokine secretion and BTLA.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis

Ashraf J. Abusamra;Zhaohui Zhong;Zhaohui Zhong;Xiufen Zheng;Mu Li.
Blood Cells Molecules and Diseases (2005)

442 Citations

Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis

Neil H Riordan;Thomas E Ichim;Wei-Ping Min;Hao-Hao Wang.
Journal of Translational Medicine (2009)

377 Citations

Identification of Viruses in Patients With Postviral Olfactory Dysfunction

Motohiko Suzuki;Koichi Saito;Wei-Ping Min;Costin Vladau.
Laryngoscope (2007)

368 Citations

Inhibitory Feedback Loop Between Tolerogenic Dendritic Cells and Regulatory T Cells in Transplant Tolerance

Wei-Ping Min;Dejun Zhou;Thomas E. Ichim;Gill H. Strejan.
Journal of Immunology (2003)

332 Citations

Dendritic Cells Genetically Engineered to Express Fas Ligand Induce Donor-Specific Hyporesponsiveness and Prolong Allograft Survival

Wei-Ping Min;Reginald Gorczynski;Xu-Yan Huang;Michelle Kushida.
Journal of Immunology (2000)

306 Citations

Immune Modulation by Silencing IL-12 Production in Dendritic Cells Using Small Interfering RNA

Jonathan A. Hill;Thomas E. Ichim;Thomas E. Ichim;Kornel P. Kusznieruk;Mu Li;Mu Li.
Journal of Immunology (2003)

200 Citations

An Immunoadhesin Incorporating the Molecule OX-2 Is a Potent Immunosuppressant That Prolongs Allo- and Xenograft Survival

Reginald M. Gorczynski;Mark S. Cattral;Zhigi Chen;Jiang Hu.
Journal of Immunology (1999)

195 Citations

NK Cells Induce Apoptosis in Tubular Epithelial Cells and Contribute to Renal Ischemia-Reperfusion Injury

Zhu-Xu Zhang;Shuang Wang;Shuang Wang;Xuyan Huang;Xuyan Huang;Wei-Ping Min.
Journal of Immunology (2008)

185 Citations

Immune Modulation and Tolerance Induction by RelB-Silenced Dendritic Cells through RNA Interference

Mu Li;Xusheng Zhang;Xiufen Zheng;Dameng Lian.
Journal of Immunology (2007)

171 Citations

Feasibility investigation of allogeneic endometrial regenerative cells.

Zhaohui Zhong;Amit N. Patel;Thomas E. Ichim;Neil H. Riordan.
Journal of Translational Medicine (2009)

156 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Wei-Ping Min

Angus W. Thomson

Angus W. Thomson

University of Pittsburgh

Publications: 41

Reginald M. Gorczynski

Reginald M. Gorczynski

University of Toronto

Publications: 33

Anthony M. Jevnikar

Anthony M. Jevnikar

University of Western Ontario

Publications: 19

Paul D. Robbins

Paul D. Robbins

University of Minnesota

Publications: 16

Catharien M. U. Hilkens

Catharien M. U. Hilkens

Newcastle University

Publications: 15

Bertha Garcia

Bertha Garcia

University of Western Ontario

Publications: 15

Maria-Cristina Cuturi

Maria-Cristina Cuturi

University of Nantes

Publications: 15

Paul R. Sanberg

Paul R. Sanberg

University of South Florida

Publications: 15

Massimo Trucco

Massimo Trucco

Carnegie Mellon University

Publications: 14

John D. Isaacs

John D. Isaacs

Newcastle University

Publications: 13

Adrian E. Morelli

Adrian E. Morelli

University of Pittsburgh

Publications: 13

Alexis M. Kalergis

Alexis M. Kalergis

Pontificia Universidad Católica de Chile

Publications: 10

Huang-Ge Zhang

Huang-Ge Zhang

University of Louisville

Publications: 10

Mohamed R. Daha

Mohamed R. Daha

University Medical Center Groningen

Publications: 10

Xuetao Cao

Xuetao Cao

Nankai University

Publications: 10

Steven H. Sacks

Steven H. Sacks

King's College London

Publications: 9

Trending Scientists

Jianhua Ma

Jianhua Ma

Hosei University

Mark S. Daskin

Mark S. Daskin

University of Michigan–Ann Arbor

Brian Chemel

Brian Chemel

Till Financial

Terrence L. Blevins

Terrence L. Blevins

Emerson (Sweden)

Richard A. Glennon

Richard A. Glennon

Virginia Commonwealth University

Wolfgang R. Hess

Wolfgang R. Hess

University of Freiburg

Martin Pickford

Martin Pickford

Sorbonne University

Liisa M. Jantunen

Liisa M. Jantunen

University of Toronto

Ravi Bansal

Ravi Bansal

University of Southern California

Gabriel A. Radvansky

Gabriel A. Radvansky

University of Notre Dame

Kimberly A. Tyler

Kimberly A. Tyler

University of Nebraska–Lincoln

Pamela K. Keel

Pamela K. Keel

Florida State University

Michael J. Birrer

Michael J. Birrer

University of Arkansas for Medical Sciences

Luigi Naldi

Luigi Naldi

Centro Studi GISED

Margaret G. McKeown

Margaret G. McKeown

University of Pittsburgh

Ricky N. Bluthenthal

Ricky N. Bluthenthal

University of Southern California

Something went wrong. Please try again later.